RxDoctor Payments Data

Sara Cothran, APRN

Gerontology · Greenwood, SCNPI 1750150512

Payments from drug & device makers

$880in general payments, 2019–2025

Across 42 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$198
  • Novo Nordisk$181
  • Edwards Lifesciences$77
  • Lilly USA, LLC$61
  • Amgen$60
  • Xeris Pharmaceuticals, Inc.$46
  • plus $256 from 10 others

What the payments were for

  • Food & beverage$880100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$880 in reported general payments places this provider in the 50th percentile of 137 gerontology providers in South Carolina.

See all gerontology providers in South Carolina

Medicare billing

Part B allowed, 2024
$66,566
Medicare patients
310
Services billed
1,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$13,260
Memantine Hcl23$608
Albuterol Sulfate HfaAlbuterol Sulfate21$554
Metoprolol Succinate22$381
Atorvastatin Calcium36$367
Gabapentin46$331
Levothyroxine Sodium37$289
Pantoprazole Sodium18$270
Fluticasone Propionate20$261
Losartan Potassium37$254
Duloxetine Hcl15$239
Amlodipine Besylate33$196
Azithromycin36$170
Escitalopram Oxalate25$159
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$159

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$181$13,26015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 137 gerontology providers in South Carolina.

Other gerontology in Greenwood

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →